热门肿瘤学SCI期刊推荐

所属栏目：学术知识
发布时间：2023-11-16 17:03:27  更新时间：2023-11-17 10:33:54

1：World Journal of Surgical Oncology创刊于2003年，出版周期是Irregular，目前的影响因子是1.966，根据网友评价审稿速度大概是平均3月录用比例是约75%。

中文简介：《世界外科肿瘤学杂志》发表与外科肿瘤学及其相关学科的文章，如流行病学、癌症研究、生物标志物、预防、病理学、放射学、癌症治疗、临床试验、多模态治疗和分子生物学。重点放在原始研究文章上。该杂志还发表重要的临床病例报告，以及对选定主题的平衡和及时的评论。肿瘤学是一个多学科的超级专业，外科肿瘤学是其中一个组成部分，尤其是实体瘤。世界各地的外科肿瘤学家都参与了从检测癌症病因的机制到治疗和预防的研究。外科肿瘤学家的作用扩展到整个护理的连续性。随着诊断和治疗的不断发展，外科肿瘤学家的角色也在不断变化。因此，《世界外科肿瘤学杂志》旨在让读者了解最新的进展，这些进展最终将影响外科肿瘤学家的工作。开放存取《世界外科肿瘤学杂志》发表的所有文章在出版后立即免费永久在线访问，不收取订阅费或注册障碍。有关开放式访问的更多信息，请参见此处。

2：CANCER出版周期是Semimonthly，目前的影响因子是6.102，根据网友评价审稿速度大概是很快,2-3周录用比例是较易。

英文简介：Cancer, an international interdisciplinary journal of the American Cancer Society, publishes high-impact, peer-reviewed original articles and solicited content on the latest clinical research findings. Each issue of Cancer strives to be comprehensive, spanning the breadth of oncology disciplines and providing something for everyone involved in cancer research, risk reduction, treatment, and patient care.Aims and ScopeCancer seeks to impart highly relevant and timely information to a broad audience of oncology and related specialists in the field. Cancer accomplishes this objective by publishing original and review articles that facilitate the transfer of knowledge from the laboratory to the bedside; contribute to cancer prevention, early detection, diagnosis, cure, and rehabilitation; and diminish suffering from cancer. Cancer also publishes educational supplements on various topics that are of interest to a broad oncology audience..ReadershipOncologists and Oncology Specialists, Hematologists, Radiologists, Basic Science Researchers, Epidemiologists, Pathologists, Cancer Prevention Researchers, Urologists, Gynecologists, Gastroenterologists, Endocrinologists, Pulmonologists, and OtolaryngologistsKeywordsCancer, Diseases, Endocrine disorders, breast cancer, blood diseases, cancer statistics, cancer diagnosis

中文简介：《癌症》是美国癌症学会的一份国际跨学科期刊，发表了影响深远、同行评议的原创文章，并就最新的临床研究成果征集内容。癌症的每一个问题都力求全面，跨越肿瘤学学科的广度，为参与癌症研究、风险降低、治疗和患者护理的每个人提供一些东西。目标和范围癌症致力于向广大的肿瘤学和相关领域的专家提供高度相关和及时的信息。癌症通过发表原创和评论文章来实现这一目标，这些文章有助于将知识从实验室转移到临床；为癌症预防、早期发现、诊断、治疗和康复作出贡献;减少癌症带来的痛苦。《癌症》杂志还就广大肿瘤学读者感兴趣的各种主题出版教育补刊。读者肿瘤学家和肿瘤学专家、血液学家、放射科医生、基础科学研究人员、流行病学家、病理学家、癌症预防研究人员、泌尿科医生、妇科医生、胃肠科医生、内分泌科医生、肺科医生和耳鼻喉科医生关键字癌症，疾病，内分泌紊乱，乳腺癌，血液病，癌症统计，癌症诊断

3：Oncogenesis目前的影响因子是5.995，。

英文简介：Oncogenesis is a peer-reviewed open access online journal that publishes full-length papers, reviews, and short communications exploring the molecular basis of cancer and related phenomena. It seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics.Oncogenesis seeks to encompass the breadth of the molecular biology of malignant change, and topics of particular interest include:ApoptosisCancer metabolismCell cycle and growth regulationCellular oncogenesCellular transformation and immortalizationDNA damage and repairMode of action of cancer therapeuticsMolecular oncologyNovel targeted therapiesSenescenceTumour suppressionVirus-induced oncogenesis

中文简介：《肿瘤发生》是一本经同行评审的开放访问在线期刊，发表全文论文、评论和简短的交流，探索癌症和相关现象的分子基础。它致力于促进分子生物学、细胞生物学、肿瘤学和遗传学的多样化和综合领域。肿瘤发生试图涵盖恶性变化的分子生物学的广度，特别感兴趣的主题包括：细胞凋亡癌症代谢细胞周期与生长调节细胞癌基因细胞转化与永生DNA损伤与修复癌症治疗的作用方式分子肿瘤学新型靶向治疗衰老肿瘤抑制病毒诱导的肿瘤发生

4：Photodiagnosis and Photodynamic Therapy创刊于2004年，出版周期是Quarterly，目前的影响因子是2.589，根据网友评价审稿速度大概是较慢,6-12周录用比例是较易。

英文简介：Official Journal of the European Platform for Photodynamic MedicineAffiliated with the International Photodynamic AssociationAlso affiliated with the British Medical Laser Association and the Polish Society for Photodynamic MedicineINDEXED in MEDLINE/PubMed, SciSearch/Science Citation Index Expanded, Current Contents/Clinical Medicine.Photodiagnosis and Photodynamic Therapy is an international journal for the dissemination of scientific knowledge and clinical developments of Photodiagnosis and Photodynamic Therapy in all medical specialties. The journal publishes original articles, review articles, case presentations, "how-to-do-it" articles, Letters to the Editor, short communications and relevant images with short descriptions. All submitted material is subject to a strict peer-review process.

中文简介：欧洲光动力医学平台官方期刊隶属于国际光动力协会也隶属于英国医学激光协会和波兰光动力医学会。在medline/pubmed中建立索引，扩展sciesearch/science引文索引，当前内容/临床医学。光诊断和光动力疗法是一种国际性的杂志，旨在在所有医学专业传播光诊断和光动力疗法的科学知识和临床发展。该期刊发表原创文章、评论文章、案例陈述、“如何做到”文章、致编辑的信函、简短的交流和相关图片，并附有简短的描述。所有提交的材料都要经过严格的同行评审。

5：Current Oncology Reports创刊于1999年，目前的影响因子是3.949，根据网友评价审稿速度大概是较慢,6-12周。

英文简介：Current Oncology Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal serves all those involved in the diagnosis, treatment, management, and prevention of cancer.

中文简介：当前肿瘤学报告提供了国际专家就该领域最重要进展所作的深入审查文章。通过提出清晰、有见地、平衡的评论，强调最近发表的重要论文，该杂志服务于所有涉及癌症诊断、治疗、管理和预防的人。

6：EJSO创刊于1985年，出版周期是Monthly，目前的影响因子是3.379，根据网友评价审稿速度大概是偏慢,4-8周录用比例是容易。

英文简介：Surgical Oncology has finally come of age and EJSO continues to play a major role in dissemination of information and knowledge relating to this surgical specialty. Published eight times a year, it presents original articles and state-of-the-art reviews of immediate interest to surgical oncologists. In addition, papers are published on chemotherapy, radiotherapy, epidemiology and pathology of cancer. The articles published also reflect the importance of communication between the laboratory and the clinician. Features Include: Clinical Trials Section Clinical Debate Section Early 'fast-track' publication Regular Reviews Education Section Research Areas Include: Epidemiology and preventive aspects of oncology Diagnosis, including imaging All aspects of therapy, including radiotherapy and chemotherapy Application of new equipment to surgical and clinical oncology Methods of assessing results of treatment Case reports that advance clinical and pathological knowledge Computing in relation to oncology EJSO is abstracted/indexed by: Index Medicus; EMBASE; ASCA; Science Citation Index.

中文简介：外科肿瘤学终于成熟了，EJSO继续在传播与该外科相关的信息和知识方面发挥着重要作用。每年出版八次，向外科肿瘤学家提供最新的文章和最新的评论。此外，论文还发表在化疗、放疗、流行病学和癌症病理学方面。发表的文章也反映了实验室和临床医生之间交流的重要性。特点包括：临床试验部分临床辩论部分早期“快速通道”出版物定期回顾教育部分研究领域包括：流行病学和肿瘤诊断预防方面，包括影像学治疗的各个方面，包括放射治疗和化疗新设备在外科和临床中的应用。肿瘤学评估肿瘤治疗病例报告结果的方法，推进了与肿瘤学EJSO相关的临床和病理学知识计算，其摘要/索引方法为：索引Medicus；EMBASE；ASCA；科学引文索引。

7：TECHNOLOGY IN CANCER RESEARCH & TREATMENT创刊于2002年，出版周期是Bimonthly，目前的影响因子是1.481，根据网友评价审稿速度大概是平均2月录用比例是约80%。

英文简介：Technology in Cancer Research and Treatment welcomes manuscripts from active investigators involved in technologies devoted to early diagnosis, treatment, and palliation of cancer. The Journal will include both experimental and theoretical investigations. Among the topics that will be covered are MRI, including functional MRI, spiral CT, PET, optical spectroscopy, computer-aided reconstruction of tumors, computer-aided drug design, stereotactic radiosurgery, cryosurgery, brachytherapy, electroporation, photodynamic therapy, gene therapy, cancer vaccine, proteomics, and genomics, as they impact cancer research and treatment. Special emphasis will be given to non-invasive techniques. The Journal publishes original articles, express communications, opinion pieces, and timely reviews.

中文简介：癌症研究和治疗技术欢迎从事癌症早期诊断、治疗和姑息治疗技术的积极研究人员的手稿。该杂志将包括实验和理论研究。将涉及的主题包括MRI，包括功能MRI、螺旋CT、PET、光谱学、肿瘤计算机辅助重建、计算机辅助药物设计、立体定向放射外科、冷冻外科、近距离治疗、电孔治疗、光动力治疗、基因治疗、癌症疫苗、蛋白质组学和基因组学，因为它们影响癌症的研究和治疗。将特别强调非侵入性技术。该杂志发表原创文章，表达沟通，发表意见，并及时发表评论。

8：Therapeutic Advances in Medical Oncology目前的影响因子是5.67，。

英文简介：Therapeutic Advances in Medical Oncology (TAM) is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies in the medical treatment of cancer. The journal is a member of the Committee on Publication Ethics (COPE).Therapeutic Advances in Medical Oncology delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of cancer. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in medical oncology, providing an online forum for rapid dissemination of recent research and perspectives in this area.The editors welcome original research articles across all areas of oncology.The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; a first editorial decision is generally reached within 3 weeks of submission and Online First publication is usually within 3 weeks of Acceptance.

中文简介：《肿瘤学治疗进展》(TAM)是一份经过同行评审的开放获取期刊，专注于癌症医学治疗方面的开拓性努力和创新研究。该杂志是出版伦理委员会(COPE)的成员之一。医学肿瘤学的治疗进展提供了最高质量的同行评审的原始研究文章、评论和学术评论，对癌症医学治疗的开创性努力和创新性研究。该杂志具有很强的临床和药理学焦点，旨在吸引临床和医学肿瘤学研究人员的国际观众，为该领域的最新研究和观点的快速传播提供在线论坛。编辑们欢迎所有肿瘤学领域的原创研究文章。该杂志主要发表原创研究文章和评论文章。原始研究手稿可能包括实验室、动物或人类/临床研究——所有阶段。给编辑的信和案例报告也将被考虑。审查文章包括专家意见/观点审查（包括单药和药物类审查）、叙述性审查和治疗领域审查。系统综述、荟萃分析、邮戳和健康经济和药物经济评论也受到欢迎。应遵循适当的赤道网络报告指南（如随机对照试验联合会和系统回顾/荟萃分析Prisma）。该杂志赞同ICMje的要求，即临床试验应在首次患者登记时或之前在世卫组织批准的公共试验登记处登记。但是，与所有试验活动一致，如果可以接受延迟注册的理由，将考虑回顾性注册试验。该杂志坚持一个盲目的审查过程，在这个过程中，审查者的名字通常不会透露给作者，除非审查者要求公开他们的身份。手稿由至少两名评审人进行评审；第一次编辑决定通常在提交后3周内作出，在线第一次出版通常在接受后3周内作出。

9：CANCER LETTERS创刊于1975年，出版周期是Biweekly，目前的影响因子是6.508，根据网友评价审稿速度大概是约2.7个月录用比例是约52.27%。

英文简介：Carcinogenesis is a multi-disciplinary journal designed to bring together all the varied aspects of research which will ultimately lead to the prevention of cancer in man. the journal will publish full papers and short communications which warrant prompt publication in the areas of viral physical and chemical carcinogenesis and mutagenesis; factors modifying these processes such as DNA repair genetics and nutrition; metabolism of carcinogens; the mechanism of action of carcinogens and promoting agents; epidemiological studies; and the formation detection identification and quantification of environmental carcinogens. Accelerated papers are of important and timely work chosen by the editors which merit a fast review process followed by rapid publication (6 weeks). The editors may from time to time invite commentaries or short reviews.

中文简介：《癌症快报》是一本在癌症研究的广泛领域提供快速发表的简短文章的杂志。该杂志重点介绍了癌症的分子和细胞生物学、癌基因、致癌、辐射生物学、分子病理学、激素和癌症、病毒肿瘤学、癌症和转移生物学、分子细胞遗传学、流行病学和实验治疗学。出版的主要标准是多学科受众的兴趣。论文应该简短，但技术上健全，并由足够的实验细节证实。如果临床论文有助于理解疾病的基本机制，将被接受。2001年1月起发表在《癌症快报》上的论文将分为以下几部分：致癌与癌症预防、实验治疗、流行病学与分子流行病学、分子与细胞生物学、肿瘤生物学。敬请作者在向适当的编辑办公室提交手稿时，选择希望其手稿出现的部分（有关详细信息，请参阅《作者指南》）。

10：Clinical & Translational Oncology创刊于2005年，出版周期是Monthly，目前的影响因子是2.441，根据网友评价审稿速度大概是平均2.2月录用比例是约50%。

英文简介：Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of biomarkers for cancer diagnosis, prognosis or prediction of treatment response, identification of new targets for cancer therapy, as well as development of new technologies for research and treatment of cancer are the major themes covered by both the educational series and research articles. A broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.

中文简介：《临床与转化肿瘤学》是一本致力于促进实验肿瘤学与临床肿瘤学相互作用的国际期刊。它涵盖了癌症研究的所有方面，从涉及肿瘤细胞和分子生物学的更基本的发现，到最先进的传统和新药的临床检测。此外，该杂志致力于促进从基础实验室到临床实践的知识转移，出版了一系列致力于缩小分子肿瘤学家和临床肿瘤学家之间差距的教育系列。肿瘤分子生物学、癌症诊断生物标记物的识别、治疗反应的预后或预测、癌症治疗新靶点的识别以及癌症研究和治疗新技术的开发是教育系列和研究文章的主题。将考虑发表广泛的主题，包括疾病的分子和细胞基础、病因学、病理生理学、病理学、流行病学、临床特征以及癌症的诊断、预后和治疗。

月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！